EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rubiadin Mediates the Upregulation of Hepatic Hepcidin and Alleviates Iron Overload via BMP6/SMAD1/5/9-Signaling Pathway

Xueting Xie, Linyue Chang, Xinyue Zhu, Fengbei Gong, Linlin Che, Rujun Zhang, Lixin Wang, Chenyuan Gong, Cheng Fang, Chao Yao, Dan Hu, Weimin Zhao und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xueting Xie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Pathogenic Biology, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203…. Hauptthemen laut MEDLINE: Hepcidins, Iron Overload, Signal Transduction, Bone Morphogenetic Protein 6. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, National Key R&D Program "Strategic Scientific and Technological Innovation Cooperation" Key Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron overload disease is characterized by the excessive accumulation of iron in the body. To better alleviate iron overload, there is an urgent need for safe and effective small molecule compounds. Rubiadin, the active ingredient derived from the Chinese herb Prismatomeris tetrandra, possesses notable anti-inflammatory and hepatoprotective properties. Nevertheless, its impact on iron metabolism remains largely unexplored. To determine the role of rubiadin on iron metabolism, Western blot analysis, real-time PCR analysis, and the measurement of serum iron were performed. Herein, we discovered that rubiadin significantly downregulated the expression of transferrin receptor 1, ferroportin 1, and ferritin light chain in ferric-ammonium-citrate-treated or -untreated HepG2 cells. Moreover, intraperitoneal administration of rubiadin remarkably decreased serum iron and duodenal iron content and upregulated expression of hepcidin mRNA in the livers of high-iron-fed mice. Mechanistically, bone morphogenetic protein 6 (BMP6) inhibitor LDN-193189 completely reversed the hepcidin upregulation and suppressor of mother against decapentaplegic 1/5/9 (SMAD1/5/9) phosphorylation induced by rubiadin. These results suggested that rubiadin increased hepcidin expression through the BMP6/SMAD1/5/9-signaling pathway. Collectively, our findings uncover a crucial mechanism through which rubiadin modulates iron metabolism and highlight it as a potential natural compound for alleviating iron-overload-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepcidinsIron OverloadSignal TransductionBone Morphogenetic Protein 6LiverAnimalsHumansMiceHep G2 CellsUp-RegulationMaleIronMice, Inbred C57BLSmad ProteinsPyrazolesPyrimidines

Stichwörter der Autor:innen

BMP6/SMAD1/5/9-signaling pathwayhepcidiniron metabolismiron overloadrubiadin

Substanzen

HepcidinsBone Morphogenetic Protein 6IronSmad ProteinsLDN 193189PyrazolesPyrimidines

Autor:innen und Institutionen

  • Department of Immunology and Pathogenic Biology, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Center for Traditional Chinese Medicine and Immunology Research, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Natural Product Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.
  • School of Acupuncture, Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, 1200 CaiLun Rd., Shanghai 201203, China.

ORCID-Profile: Yufu Zhou

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • National Key R&D Program "Strategic Scientific and Technological Innovation Cooperation" Key Project
  • National Key R&D Program “Strategic Scientific and Technological Innovation Cooperation” Key Project

Zitieren

APA

Xie, X., Chang, L., Zhu, X., Gong, F., Che, L., Zhang, R., Wang, L., Gong, C., Fang, C., Yao, C., Hu, D., Zhao, W., Zhou, Y., & Zhu, S. (2025). Rubiadin Mediates the Upregulation of Hepatic Hepcidin and Alleviates Iron Overload via BMP6/SMAD1/5/9-Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031385

Vancouver

Xie X, Chang L, Zhu X, Gong F, Che L, Zhang R, et al. Rubiadin Mediates the Upregulation of Hepatic Hepcidin and Alleviates Iron Overload via BMP6/SMAD1/5/9-Signaling Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031385

BibTeX
@article{Xie2025,
  author = {Xie, Xueting and Chang, Linyue and Zhu, Xinyue and Gong, Fengbei and Che, Linlin and Zhang, Rujun and Wang, Lixin and Gong, Chenyuan and Fang, Cheng and Yao, Chao and Hu, Dan and Zhao, Weimin and Zhou, Yufu and Zhu, Shiguo},
  title = {Rubiadin Mediates the Upregulation of Hepatic Hepcidin and Alleviates Iron Overload via BMP6/SMAD1/5/9-Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031385}
}
Kostenlos starten →